Logo image of WEST

WESTROCK COFFEE CO (WEST) Stock Fundamental Analysis

USA - NASDAQ:WEST - US96145W1036 - Common Stock

4.53 USD
+0.02 (+0.44%)
Last: 10/8/2025, 5:23:57 PM
4.53 USD
0 (0%)
After Hours: 10/8/2025, 5:23:57 PM
Fundamental Rating

1

Taking everything into account, WEST scores 1 out of 10 in our fundamental rating. WEST was compared to 87 industry peers in the Food Products industry. WEST may be in some trouble as it scores bad on both profitability and health. WEST does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

WEST had negative earnings in the past year.
In the past year WEST has reported a negative cash flow from operations.
In the past 5 years WEST reported 4 times negative net income.
In the past 5 years WEST always reported negative operating cash flow.
WEST Yearly Net Income VS EBIT VS OCF VS FCFWEST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M -150M -200M

1.2 Ratios

With a Return On Assets value of -4.07%, WEST is not doing good in the industry: 65.52% of the companies in the same industry are doing better.
WEST has a Return On Equity of -10.18%. This is in the lower half of the industry: WEST underperforms 67.82% of its industry peers.
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WEST Yearly ROA, ROE, ROICWEST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

Looking at the Gross Margin, with a value of 16.27%, WEST is in line with its industry, outperforming 44.83% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for WEST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEST Yearly Profit, Operating, Gross MarginsWEST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 -5 10 15

1

2. Health

2.1 Basic Checks

WEST does not have a ROIC to compare to the WACC, probably because it is not profitable.
WEST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WEST Yearly Shares OutstandingWEST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
WEST Yearly Total Debt VS Total AssetsWEST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.09, we must say that WEST is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.09, WEST is doing worse than 68.97% of the companies in the same industry.
WEST has a Debt/Equity ratio of 0.89. This is a neutral value indicating WEST is somewhat dependend on debt financing.
WEST has a worse Debt to Equity ratio (0.89) than 67.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACCN/A
WACC8.52%
WEST Yearly LT Debt VS Equity VS FCFWEST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

A Current Ratio of 1.31 indicates that WEST should not have too much problems paying its short term obligations.
WEST's Current ratio of 1.31 is on the low side compared to the rest of the industry. WEST is outperformed by 62.07% of its industry peers.
WEST has a Quick Ratio of 1.31. This is a bad value and indicates that WEST is not financially healthy enough and could expect problems in meeting its short term obligations.
WEST has a Quick ratio of 0.68. This is in the lower half of the industry: WEST underperforms 65.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.68
WEST Yearly Current Assets VS Current LiabilitesWEST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

3

3. Growth

3.1 Past

The earnings per share for WEST have decreased strongly by -70.91% in the last year.
EPS 1Y (TTM)-70.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%34.78%

3.2 Future

Based on estimates for the next years, WEST will show a very strong growth in Earnings Per Share. The EPS will grow by 33.91% on average per year.
Based on estimates for the next years, WEST will show a quite strong growth in Revenue. The Revenue will grow by 17.77% on average per year.
EPS Next Y18.63%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue Next Year26.58%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A

3.3 Evolution

WEST Yearly Revenue VS EstimatesWEST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 500M 1B
WEST Yearly EPS VS EstimatesWEST Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

WEST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 55.51 indicates a quite expensive valuation of WEST.
WEST's Price/Forward Earnings ratio is in line with the industry average.
WEST is valuated expensively when we compare the Price/Forward Earnings ratio to 23.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 55.51
WEST Price Earnings VS Forward Price EarningsWEST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

62.07% of the companies in the same industry are cheaper than WEST, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.02
WEST Per share dataWEST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WEST does not grow enough to justify the current Price/Earnings ratio.
WEST's earnings are expected to grow with 33.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.63%
EPS Next 3Y33.91%

0

5. Dividend

5.1 Amount

No dividends for WEST!.
Industry RankSector Rank
Dividend Yield N/A

WESTROCK COFFEE CO

NASDAQ:WEST (10/8/2025, 5:23:57 PM)

After market: 4.53 0 (0%)

4.53

+0.02 (+0.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners37.72%
Inst Owner Change0%
Ins Owners6.03%
Ins Owner Change0.76%
Market Cap429.04M
Analysts83.64
Price Target10.46 (130.91%)
Short Float %14.95%
Short Ratio9.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3070.57%
Min EPS beat(2)-6671.48%
Max EPS beat(2)530.34%
EPS beat(4)1
Avg EPS beat(4)-2146.95%
Min EPS beat(4)-6671.48%
Max EPS beat(4)530.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.65%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-6.76%
Revenue beat(4)0
Avg Revenue beat(4)-7.83%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-6.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.09%
PT rev (3m)-3.3%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 55.51
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 1.11
P/tB 2.88
EV/EBITDA 27.02
EPS(TTM)-0.94
EYN/A
EPS(NY)0.08
Fwd EY1.8%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS11.3
BVpS4.1
TBVpS1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.27%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 15.65
Cap/Depr 619.86%
Cap/Sales 15.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.68
Altman-Z 1.09
F-Score2
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)327.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-15%
EPS Next Y18.63%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%34.78%
Revenue Next Year26.58%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
EBIT growth 1Y-133.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1139.04%
EBIT Next 3Y219.97%
EBIT Next 5Y148.98%
FCF growth 1Y-90.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.13%
OCF growth 3YN/A
OCF growth 5YN/A